Generic Drug Market 2019

Language:
Japanese
Product Code No:
C61113600
Issued In:
2019/09
#of Pages:
154
Publication Cycle:
  
Format:
PDF

Buy this research

Price:
120,000 yen ($1,092.10)(excluding consumption tax)
* Equivalent value in US$ (Today's rate : $1= 109.88 yen , 2020/01/23 Japan)

Coverage: (Product/service)

Generic Drugs

Research Target:

Generic Drugs manufacturers

Research Content:

I   Real Status of Generic Drugs Market in Japan

  • New goal has been set for the ratio of generic drugs used should be 80% in volume by 2020.
  • The goal to occupy 80% of the entire volume of drugs used can be achieved soon, but the market of generic drugs is still vague.
  • Japan Generic Medicines Association proposed the “Vision for Next Generation Industry” for “post-80%”
  • Changes in Market Trends of Medical Drugs
  • Market Trends of Generic Drugs

II    Strategies and Outlook of Generic Drugs in Pharmaceutical Companies

  • The goal to occupy 80% of the entire volume of drugs used can be achieved soon
  • Competition become more harsh as business strategy among Top 3 companies diversify
  • Foreign-affiliated pharmaceutical companies have been facing difficulties in the unique Japanese drugs market
  • As the growth of the generic drugs market having slowed down, new attempts are needed to invigorate the business.
  • Due to the increase in the generic drugs to be listed and to the attempts for preparatory design of drugs, the expenses for R&D are on the rise
  • Production system are built to meet the “80% share by September 2020”
  • Distribution strategies by the generic drug companies
  • Attempts by Japan Generic Medicines Association
  • As generic drugs being accepted by more consumers, the number of MR has been flat of slightly declined
  • As generic drugs being accepted by more consumers, the number of MR has been flat or slightly declined
  • Succession business of “branded drugs” entered new phase
  • Authorized generic drugs have been increasing the existence in the generic drug market
  • Biosimilar business has been invigorated
  • The sluggish growth of the domestic market has led some companies to enhance overseas business.
  • Attempts for multi-sourcing in procurement of API (active pharmaceutical ingredient) from the viewpoint of stable supply
  • Whether wider acceptance of a formulary be the key to expand the generic drug market.

III Company Profiles

6 enterprises

IV Real Status and Outlook of Formulary

  1. What is Formulary
  2. Standard for the use of drugs based on the idea of pharmaceutical care
  3. Quality assurance of pharmacotherapy in formulation of formulary
  4. Dual nature of formulary as effective use of generic drugs and as cost effective prescribing
  5. In DPC hospitals having formulary is a must
  6. Necessity for formulation of local formulary
  7. Clinicians manage local formulary
  8. Advantage of formulating local formulary
  9. New challenges after formulary is provided

Buy this research

written in Japanese
Price:
120,000 yen ($1,092.10)(excluding consumption tax)
* Equivalent value in US$ (Today's rate : $1= 109.88 yen , 2020/01/23 Japan)